APA (7th ed.) Citation

Varsha D. Shiragannavar, Nirmala G. Sannappa Gowda, Lakshana D. Puttahanumantharayappa, Shreyas H. Karunakara, Smitha Bhat, Shashanka K. Prasad, . . . Prasanna K. Santhekadur. (2023). The ameliorating effect of withaferin A on high-fat diet-induced non-alcoholic fatty liver disease by acting as an LXR/FXR dual receptor activator. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Varsha D. Shiragannavar, Nirmala G. Sannappa Gowda, Lakshana D. Puttahanumantharayappa, Shreyas H. Karunakara, Smitha Bhat, Shashanka K. Prasad, Shashanka K. Prasad, Divya P. Kumar, and Prasanna K. Santhekadur. The Ameliorating Effect of Withaferin A on High-fat Diet-induced Non-alcoholic Fatty Liver Disease by Acting as an LXR/FXR Dual Receptor Activator. Frontiers Media S.A., 2023.

MLA (9th ed.) Citation

Varsha D. Shiragannavar, et al. The Ameliorating Effect of Withaferin A on High-fat Diet-induced Non-alcoholic Fatty Liver Disease by Acting as an LXR/FXR Dual Receptor Activator. Frontiers Media S.A., 2023.